NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+7.55%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$999M
AUM Growth
+$211M
(+27%)
Cap. Flow
+$201M
Cap. Flow
% of AUM
20.12%
Top 10 Holdings %
Top 10 Hldgs %
44.45%
Holding
134
New
12
Increased
34
Reduced
52
Closed
15
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$99.2M |
| 2 |
Evolus
EOLS
|
$26.2M |
| 3 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$22.9M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$15.3M |
| 5 |
Establishment Labs
ESTA
|
$15.1M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$9.24M |
| 2 |
Cytokinetics
CYTK
|
$5.78M |
| 3 |
RH
RH
|
$5.51M |
| 4 |
Immatics
IMTX
|
$5.34M |
| 5 |
Ventyx Biosciences
VTYX
|
$5.13M |
Sector Composition
| 1 | Healthcare | 59.27% |
| 2 | Consumer Discretionary | 14.15% |
| 3 | Financials | 7.37% |
| 4 | Communication Services | 5.83% |
| 5 | Technology | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Jasper Therapeutics
JSPR
$44.2M
| $1.76M | 0.11% |
222,827
-17,463
| -7% | -$138K |
|
77
Strata Skin Sciences
SSKN
$7.42M
| $1.72M | 0.1% |
312,813
-13,682
| -4% | -$75.3K |
|
|
IMTXW
78
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.63M | 0.1% |
558,977
| – | – |
|
|
CONN
79
DELISTED
Conn's Inc.
CONN
| $1.6M | 0.1% |
+359,371
| New | +$1.6M |
|
80
Cartesian Therapeutics
RNAC
$277M
| $1.54M | 0.09% |
74,474
+1,141
| +2% | +$23.6K |
|
81
Rezolute
RZLT
$696M
| $1.53M | 0.09% |
1,537,707
+768,101
| +100% | +$762K |
|
82
Scully Royalty
SRL
$80.8M
| $1.48M | 0.09% |
242,721
-55,770
| -19% | -$340K |
|
83
Neurogene
NGNE
$285M
| $1.4M | 0.08% |
72,279
-2,721
| -4% | -$52.7K |
|
84
B. Riley Financial
RILY
$152M
| $1.31M | 0.08% |
62,520
| – | – |
|
85
Zynex
ZYXI
$45.1M
| $1.31M | 0.08% |
+120,000
| New | +$1.31M |
|
|
EAR
86
DELISTED
Eargo, Inc. Common Stock
EAR
| $1.28M | 0.08% |
+495,582
| New | +$1.28M |
|
87
Anebulo Pharmaceuticals
ANEB
$97.8M
| $1.24M | 0.07% |
511,073
| – | – |
|
88
Cidara Therapeutics
CDTX
$1.6B
| $1.23M | 0.07% |
77,337
-49,583
| -39% | -$787K |
|
89
Fortress Biotech
FBIO
$110M
| $1.12M | 0.07% |
372,562
-28,652
| -7% | -$86.2K |
|
90
Instil Bio
TIL
$213M
| $970K | 0.06% |
127,292
+77,292
| +155% | +$589K |
|
91
Talphera
TLPH
$11.3M
| $910K | 0.05% |
1,237,519
+64,504
| +5% | +$47.4K |
|
92
SPAR Group
SGRP
$28.2M
| $888K | 0.05% |
879,189
| – | – |
|
93
Gossamer Bio
GOSS
$668M
| $614K | 0.04% |
672,856
-5,416,615
| -89% | -$4.94M |
|
94
Fossil Group
FOSL
$165M
| $592K | 0.04% |
405,278
-579,937
| -59% | -$847K |
|
|
SCTL
95
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $426K | 0.03% |
1,214,706
-35,294
| -3% | -$12.4K |
|
96
Sensus Healthcare
SRTS
$53.1M
| $417K | 0.02% |
176,750
-8,298
| -4% | -$19.6K |
|
|
GMDA
97
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $330K | 0.02% |
800,000
-3,525,000
| -82% | -$1.45M |
|
|
APTO
98
DELISTED
Aptose Biosciences, Inc.
APTO
| $305K | 0.02% |
4,004
-545
| -12% | -$41.5K |
|
|
LADR
99
Ladder Capital
LADR
$1.51B
| $295K | 0.02% |
25,631
-1,442
| -5% | -$16.6K |
|
100
Lucid Diagnostics
LUCD
$140M
| $211K | 0.01% |
149,698
-8,437
| -5% | -$11.9K |
|